Is Shattuck Labs, Inc. (STTK) a Buy, Sell, or Hold?
NASDAQ : STTK
Shattuck Labs, Inc. — Institutional Ownership
$7.2 USD
$0.02 (0.28%)
- Volume
- 33.24K
- Average Volume
- 1.04M
- Market Capitalization
- $650.68M
- P/E Ratio
- -14.12
- Dividend Yield
- 0.00%
- Price Target
- $12.50
- Year High
- $8.33
- Year Low
- $0.76
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.59
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-17 | Redmile Group, LLC | 10.02M | 9.90% |
| 2026-07-17 | Redmile Biopharma Investments II, L.P. | 8.13M | 8.10% |
| 2026-07-17 | Jeremy C. Green | 10.02M | 9.90% |
| 2026-06-17 | Deep Track Capital, LP | 5M | 5.17% |
| 2026-06-15 | ORBIMED ADVISORS LLC | 9.02M | 9.99% |
| 2026-06-15 | OrbiMed Capital GP IX LLC | 7.52M | 8.33% |
| 2026-06-15 | OrbiMed Genesis GP LLC | 1.5M | 1.67% |
| 2026-06-11 | Redmile Biopharma Investments II, L.P. | 6.12M | 6.20% |
| 2026-06-11 | Redmile Group, LLC | 9.82M | 9.90% |
| 2026-06-11 | Jeremy C. Green | 9.82M | 9.90% |
| 2026-05-15 | T. Rowe Price Investment Management, Inc. | 9.87M | 13.80% |
| 2026-02-06 | T. Rowe Price Investment Management, Inc. | 7.37M | 11.70% |
| 2025-11-13 | Prosight Management, LP | 6.54M | 9.90% |
| 2025-09-02 | OrbiMed Genesis GP LLC | 1.05M | 1.67% |
| 2025-09-02 | OrbiMed Capital GP IX LLC | 5.26M | 8.32% |
| 2025-09-02 | ORBIMED ADVISORS LLC | 6.31M | 9.99% |
| 2025-08-26 | Redmile Group, LLC | 6.38M | 9.90% |
| 2025-08-26 | Jeremy C. Green | 6.38M | 9.90% |
| 2025-08-26 | Redmile Biopharma Investments II, L.P. | 4.07M | 6.40% |
| 2025-08-06 | Jeremy C. Green | 5.65M | 11.80% |
| 2025-08-06 | Redmile Group, LLC | 5.65M | 11.80% |
| 2025-08-06 | Redmile Biopharma Investments II, L.P. | 3.34M | 7.00% |
| 2025-07-29 | The Vanguard Group | 2.15M | 4.48% |
| 2025-07-16 | BlackRock, Inc. | 878.75K | 1.80% |
| 2025-02-12 | Adage Capital Management, L.P. | 4.68M | 9.79% |
| 2024-11-08 | (1) BlackRock, Inc. | 2.61M | 5.50% |
| 2024-10-24 | (1) BlackRock, Inc. | 2.61M | 5.50% |
| 2024-01-29 | Adage Capital Management, L.P. | 2.58M | 5.47% |
| 2024-01-29 | Robert Atchinson | 2.58M | 5.47% |
| 2024-01-29 | Adage Capital Partners GP, L.L.C. | 2.58M | 5.47% |
| 2024-01-29 | Adage Capital Partners, L.P. | 2.58M | 5.47% |
| 2024-01-29 | Phillip Gross | 2.58M | 5.47% |
| 2024-01-02 | W. Lawrence Hawkins | 2.78M | 5.90% |
| 2024-01-02 | Prosight Partners, LLC | 2.78M | 5.90% |
| 2024-01-02 | Prosight Management, LP | 2.78M | 5.90% |
| 2024-01-02 | Prosight Plus Fund, LP | 726.08K | 1.50% |
| 2024-01-02 | Prosight Fund, LP | 244.55K | 0.50% |
| 2022-06-09 | (1) BlackRock, Inc. | 2.11M | 4.97% |
| 2022-02-14 | Oleg Nodelman | - | 11.00% |
| 2022-02-14 | EcoR1 Capital, LLC | - | 11.00% |
| 2022-02-14 | EcoR1 Capital Fund Qualified, L.P. | - | 11.00% |
| 2022-02-04 | (1) BlackRock, Inc. | 2.21M | 5.20% |
| 2021-05-17 | EcoR1 Capital Fund Qualified, L.P. | 2.52M | 11.00% |
| 2021-05-17 | EcoR1 Capital, LLC | 3.3M | 11.00% |
| 2021-05-17 | Oleg Nodelman | 3.3M | 11.00% |
| 2020-11-10 | FMR LLC | 5.93M | 14.20% |
| 2020-11-10 | Abigail P. Johnson | 5.93M | 14.20% |
| 2020-10-23 | Taylor Schreiber, M.D., Ph.D. | 2.71M | 6.50% |
| 2020-10-23 | Josiah Hornblower | 3.41M | 8.20% |
| 2020-10-15 | Jeremy C. Green | 5.62M | 13.50% |
| 2020-10-15 | Redmile Group, LLC | 5.62M | 13.50% |
| 2020-10-15 | Redmile Biopharma Investments II, L.P. | 2.18M | 5.20% |
STTK Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.65 | 69.58M | $253.99M | $54.19M | $2.42M | $202.21M |
| 2024-12-31 | $1.21 | 50.76M | $61.42M | $57.39M | $3.41M | $7.44M |
| 2023-12-31 | $7.13 | 42.6M | $303.74M | $125.63M | $4.2M | $182.32M |
| 2022-12-31 | $2.30 | 42.38M | $97.47M | $47.38M | $4.9M | $55M |
| 2021-12-31 | $8.51 | 42.03M | $357.7M | $92.27M | -$ | $265.43M |
| 2020-12-31 | $52.41 | 41.77M | $2.19B | $157.9M | -$ | $2.03B |
| 2019-12-31 | $19.35 | 41.74M | $807.75M | $7.01M | -$ | $800.74M |
| 2018-12-31 | $19.35 | 15.04M | $291.1M | $31.64M | -$ | $259.46M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.94 | 129.78M | $900.67M | $63.3M | $2.67M | $840.04M |
| 2026-03-31 | $6.43 | 112.23M | $721.67M | $90.42M | $2.89M | $634.14M |
| 2025-12-31 | $3.65 | 103.78M | $378.81M | $54.19M | $2.42M | $327.04M |
| 2025-09-30 | $2.39 | 72.18M | $172.52M | $42.55M | $2.63M | $132.6M |
| 2025-06-30 | $0.79 | 51M | $40.38M | $50.47M | $2.97M | -$7.11M |
| 2025-03-31 | $0.95 | 50.97M | $48.42M | $60.9M | $3.19M | -$9.28M |
| 2024-12-31 | $1.21 | 50.84M | $61.52M | $57.39M | $3.41M | $7.54M |
| 2024-09-30 | $3.49 | 50.83M | $177.41M | $43.83M | $3.62M | $137.2M |
| 2024-06-30 | $3.99 | 50.79M | $202.66M | $60.69M | $3.82M | $145.78M |
| 2024-03-31 | $8.89 | 50.57M | $449.54M | $76M | $4.01M | $377.54M |
| 2023-12-31 | $7.13 | 43.01M | $306.67M | $125.63M | $4.2M | $185.25M |
| 2023-09-30 | $1.52 | 42.48M | $64.57M | $40.63M | $4.39M | $28.32M |